Back to search

University of Crete (UOC)

Structural and functional relationship of high-density lipoprotein (HDL) and its role in development of atherosclerosis

Abstract

dc:description

Cardiovascular disease (CVD) is the leading cause of mortality worldwide according to the World Health Organization (WHO) and consists of heart and blood vessel disorders such as coronary artery disease (CAD). CAD is caused by atherosclerosis, a chronic inflammatory disorder of the arterial wall, arising from an imbalance in lipid metabolism and immune responses. To date, numerous epidemiological and clinical studies have demonstrated an inverse association between the risk of developing CAD in humans and plasma high-density lipoprotein (HDL) cholesterol levels. Based on this relationship, several clinical efforts were made to decrease the CAD risk by pharmacologically increasing the HDL cholesterol levels. Nevertheless, the adverse and paradoxical findings obtained from different clinical trials, epidemiological and population studies, and genetic studies have shifted the current focus from HDL cholesterol concentration (quantity) to HDL particle functionality (quality) which incorporates many proteins and lipids with unique functions. Since the distinction between HDL cholesterol quantity and quality is crucial and reflects the beneficial pleiotropic effects of HDL, the main goal of this PhD thesis is to explore the structure-function relationship of HDL and its role in the development of atherosclerosis. In Subchapter 3.1 we studied the effect of the enzyme myeloperoxidase (MPO) on HDL structure and functionality in vivo. MPO, a leukocyte-derived peroxidase, is highly expressed during inflammation and associated with HDL by reducing its functionality and contributing to atherosclerosis. Additionally, apolipoprotein A-I (apoA-I), the primary protein component of HDL, possesses a central role in HDL biosynthesis, structure and function by interacting with a number of receptors and enzymes, including ABCA1, ABCG1, SR-BI and LCAT. The aforementioned interactions trigger the activation of atheroprotective properties of HDL such as cholesterol efflux and anti-oxidative, anti-inflammatory, anti-apoptotic and anti-thrombotic properties. Based on these, we generated recombinant adenoviruses expressing the wild type (WT) and mutant forms, Met148Ala (M148A) and Tyr192Ala (Y192A), of human apoA-I and human MPO and analyzed them in apoA-I -/- mice. Following injection of adenoviruses, we found that mice with overexpressed MPO had considerably higher plasma apoA-I and HDL levels without affecting the expression of genes related to the liver's HDL synthesis or catabolism. Next, we further examined the effect of overexpressed MPO in the liver of apoA-I -/- mice by analyzing the mRNA levels of pro- and anti-inflammatory cytokines using the RT-qPCR method. As a result, MPO overexpression reduced the expression of pro-inflammatory genes and increased or did not affect the expression of anti-inflammatory genes suggesting that MPO had no toxic effects in the liver. Moreover, we investigated the effect of WT or mutant apoA-I forms and MPO on generated HDL particles by performing two-dimensional electrophoresis (2D-PAGGE) and Fast Protein Liquid Chromatography (FPLC). In the plasma of mice overexpressing MPO, no significant alterations in HDL size or electrophoretic mobility was observed with the exception of mice expressing apoA-I (M148A) which showed enriched pre-b relative to alpha (α) HDL particles, suggesting that the apoA-I (M148A) mutation may interfere with HDL remodeling. Finally, we showed that overexpression of MPO was associated with reduced anti-oxidant capacity of HDL particles in all mice. Interestingly, HDL particles bearing apoA-I (Y192A) showed enhanced ABCA1 dependent cholesterol efflux from macrophages which was not affected by MPO and these mice had reduced levels of LDL cholesterol. The study discussed in Subchapter 3.2 was performed in collaboration with Dr. Despina Sanoudou’s laboratory in Medical School of Athens and our specific contribution was the exploration of the atheroprotective potential of reconstituted HDL (rHDL) containing human apolipoprotein E3 (apoE3), the most common variant of the polymorphic apoE, in vivo. In particular, we conducted an in vivo study using a well-established mouse model of hypercholesterolemia, atherosclerosis, and endothelial dysfunction, in the apoE-/- mice in order to assess rHDL-apoE3 under pathological conditions. Following the injection of rHDL-apoE3 in apoE-/- mice, we found that a single dose led to significantly reduced plasma LDL levels accompanied by an increased concentration of cholesterol in the liver suggesting a fast clearance of LDL particles through binding of apoE to liver receptors. Moreover, serum lipid analysis at specific time points indicated that triglyceride levels were transiently increased in mice that received rHDL-apoE3 due to fast clearance of apoE from the circulation. Lastly, in order to evaluate the impact of rHDL-apoE3 on vascular permeability, we used Evans Blue dye which binds to albumin and is transferred to adjacent tissues under pathological conditions where the endothelium becomes imperable. Based on that, we explored that a single injection of rHDL-apoE3 in the tail vein of apoE-/- mice was able to improve vascular permeability as evidenced by the reduced concentration of the dye in certain tissues such as the stomach, the tongue, and the urinary bladder. Next, in Subchapter 3.3 we generated recombinant adenovirus expressing the human GALNT2 and analyzed it in apoA-I -/- mice either fed with Chow or High Fat Diet (HFD) in order to investigate the effect of human GALNT2 on lipoprotein metabolism in vivo. Human GALNT2 is a glycotransferase and is highly correlated with O-linked glycosylation, one of the most significant forms of post-translational modifications which affects protein folding, processing, secretion and functions. Changes in the glycosylation status of proteins are associated with pathological conditions such as dyslipidemia and atherosclerosis. According to our findings, the overexpression of human GALNT2 did not affect the lipid profile of HFD-fed mice but increased the total cholesterol and LDL and decreased the HDL, triglycerides, and VLDL levels in chow-fed mice. These findings suggest that the overexpression of GALNT2 modulates lipoprotein metabolism and indicates lipoprotein metabolism related proteins as modifying substrates for glycosylation. An intriguing finding of the present study was that overexpression of human GALNT2 in chow-fed mice resulted in a significant decrease in mRNA levels of the major metabolic intermediates in the pathway of intracellular cholesterol synthesis, controlled by SREBP-2 (Sterol regulatory element-binding protein 2). Whether human GALNT2 expression in trans-Golgi and ER (endoplasmic reticulum) systems affects the activation of SREBP2 directly or indirectly through post-translational modification requires further investigation. Lastly, the study discussed in Subproject 4.4 has provided the tools for further investigation of the role of specific apoA-I residues on HDL structure and functions and the prevention and treatment of atherosclerosis. Since the study of apoA-I mutations in diseases that develop over long periods, such as atherosclerosis, with adeno-mediated transfer was prohibitive, we further developed adeno-associated viral vectors that promote the long-term expression of the gene of interest in various animal models and enabled the examination of chronic diseases. For that reason, we generated, amplified and purified recombinant adeno-associated viruses expressing apoA-I wt, apoA-I [D89A/E91A/E92A], and apoA-I [L218A/L219A/V221A/L222A] for use both in vitro and in vivo studies.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dalakoura-Karagkouni, Aikaterini
  • Δαλακούρα-Καραγκούνη, Αικατερίνη

Subjects

dc:subject × 32

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57984

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dalakoura-Karagkouni, Aikaterini; Δαλακούρα-Καραγκούνη, Αικατερίνη. Structural and functional relationship of high-density lipoprotein (HDL) and its role in development of atherosclerosis. University of Crete (UOC), 2024. http://hdl.handle.net/10442/hedi/57984